Appetite News and Research

RSS

Gut bacteria and genes jointly shape obesity risk, review reveals hidden links

Researchers examined the heritability of body mass index (BMI), highlighting that genetics and the gut microbiome both play major roles in obesity risk. The review emphasizes that maternal microbiome transmission and family environment may help explain “missing heritability” beyond known genetic factors.

20 May 2025

This news might ruin your appetite — and summer

It's a marvel of food technology: ice cream that resists melting.

20 May 2025

US withdrawal from global health bodies threatens millions with hunger and disease

A new Perspective in The American Journal of Clinical Nutrition warns of catastrophic global nutrition and health impacts if the US withdraws from the WHO and dismantles USAID. The authors urge urgent policy reversal and call for collaborative global action to prevent widespread humanitarian crises.

19 May 2025

Methotrexate found to be effective alternative to prednisone for pulmonary sarcoidosis

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects.

18 May 2025

City size reduces obesity and impulsivity through better lifestyle and education

Researchers analyzing data from 915 U.S. cities found that both obesity and impulsivity (measured by ADHD rates) are less common in larger cities, with physical inactivity linking ADHD to obesity. Education and mental healthcare access further influence these patterns, highlighting modifiable factors for urban health.

18 May 2025

GLP-1 weight loss drugs leave users low on key nutrients, study finds

This study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in essential vitamins and minerals. Despite appetite suppression and weight loss benefits, most participants exceeded fat intake recommendations and failed to meet protein and micronutrient needs.

14 May 2025

Animal research reveals metabolic differences between tirzepatide and semaglutide

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment, with tirzepatide temporarily increasing energy expenditure and semaglutide initially reducing energy expenditure.

14 May 2025

Once-daily oral treatment shows positive results in first human study for obesity treatment

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for the safe and effective redirection of nutrient absorption into the lower intestine, the weight loss and metabolic management mechanism behind gastric bypass surgery.

14 May 2025

Hormone FGF21 reverses fatty liver disease by signaling the brain

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to improve liver function.

13 May 2025

BSO drug mimics anti-obesity effects of difficult sulfur amino acid restricted diet

A new research paper was published in Aging (Aging-US) Volume 17, Issue 4, on April 7, 2025, titled "Pharmacological recapitulation of the lean phenotype induced by the lifespan-extending sulfur amino acid-restricted diet."

13 May 2025

Gaza faces growing hunger crisis amid ongoing aid blockade

The risk of famine in Gaza is increasing with the deliberate withholding of humanitarian aid, including food, in the ongoing blockade.

13 May 2025

Online obesity clinic achieves clinical trial-level weight loss with lower semaglutide doses

New research being presented at this year's European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials – but with less than half the medication.

12 May 2025

Collagen protein bars show promise for safe and effective weight loss

Research being presented at this year's European Congress on Obesity (ECO 2025) and published in the journal Nutrients indicates that collagen could be a safe and effective weight-loss supplement.

12 May 2025

GLP-1 drugs linked to significant BMI reduction in children with severe obesity

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs form part of their treatment, new research being presented at year's European Congress on Obesity (ECO 2025) suggests.

12 May 2025

Simple vest could help older adults maintain weight loss long term

Wearing a weighted vest during a 6-month calorie-restricted weight loss program helped older adults with obesity regain less weight over 24 months compared to those on diet alone. This benefit may be due to better preservation of resting metabolic rate during the intervention.

12 May 2025

Tirzepatide outperforms semaglutide in weight loss clinical trial

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.

12 May 2025

Ultra-processed food boosts addiction and worsens mood, study finds

A cross-sectional study of 3,997 adults in Türkiye found that ultra-processed food (UPF) intake is strongly linked to food addiction and negative mood. Surprisingly, no association was found between UPF consumption and hedonic hunger.

11 May 2025

Cultural comfort: How pasta became Italy’s edible happiness ritual

A multi-method study of over 1,500 Italians found that pasta consumption is consistently associated with increased happiness, especially when eaten socially. Psychological traits like mindfulness and lower stress enhanced these positive emotional effects.

11 May 2025

GLP-1 receptor agonists improve mood and metabolic health in adults with mental illness

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on mood, well-being, and quality of life in those both with and without mental illness, according to a systematic review of the available evidence being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May).

11 May 2025

Uncovering the architecture of the human sugar sensor

Our attraction to sugar has grown to an unhealthy level. The average person in the United States now consumes more than 100 pounds of the sweet stuff every year, up from 18 pounds in 1800.

7 May 2025

Appetite News and Research

Gut bacteria and genes jointly shape obesity risk, review reveals hidden links

This news might ruin your appetite — and summer

US withdrawal from global health bodies threatens millions with hunger and disease

Methotrexate found to be effective alternative to prednisone for pulmonary sarcoidosis

City size reduces obesity and impulsivity through better lifestyle and education

GLP-1 weight loss drugs leave users low on key nutrients, study finds

Animal research reveals metabolic differences between tirzepatide and semaglutide

Once-daily oral treatment shows positive results in first human study for obesity treatment

Hormone FGF21 reverses fatty liver disease by signaling the brain

BSO drug mimics anti-obesity effects of difficult sulfur amino acid restricted diet

Gaza faces growing hunger crisis amid ongoing aid blockade

Online obesity clinic achieves clinical trial-level weight loss with lower semaglutide doses

Collagen protein bars show promise for safe and effective weight loss

GLP-1 drugs linked to significant BMI reduction in children with severe obesity

Simple vest could help older adults maintain weight loss long term

Tirzepatide outperforms semaglutide in weight loss clinical trial

Ultra-processed food boosts addiction and worsens mood, study finds

Cultural comfort: How pasta became Italy’s edible happiness ritual

GLP-1 receptor agonists improve mood and metabolic health in adults with mental illness

Uncovering the architecture of the human sugar sensor

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News